Degradation of the extracellular matrix occurs under physiological and pathological conditions, thought to be principally mediated by a family of neutral proteolytic enzymes termed the matrix metalloproteinases (MMPs). 
Degradation of the extracellular matrix occurs under physiological and pathological conditions, thought to be principally mediated by a family of neutral proteolytic enzymes termed the matrix metalloproteinases (MMPs). The present study was initiated to determine whether mast cells have the ability to produce these proteases in diseased and normal human tissue. Immunohistochemistry and in situ hybridization was performed to localize interstitial collagenase protein and mRNA transcripts in diseased human tissue. The human mast cell line HMC-1 was cultured under serum free conditions, stimulated with phorbol mystrate acetate (PMA) and supernatants analyzed by Western blotting and zymography to determine the profile of secreted MMPs. The dog mast cell line BR, known to secrete gelatinolytic enzymes, was used in parallel studies. Total RNA was extracted and analyzed by RT-PCR for the expression of tissue inhibitors of MMP (TIMPs). Collagenase-1 protein and mRNA were expressed by tryptase and chymase positive human mast cells in all tissue analyzed. This proteinase wa also detected in the cytoplasm and conditioned media of HMC-1 cells. PMA induced gelatinolytic activity in both mast cell lines examined. TIMP-1 immunoreactivity was detected and TIMP-1, and-2 (but not TIMP-3) mRNA transcripts were amplified from HMC-1 cells. This is the first demonstration of the expression of collagenase-1 by human mast cells in both inflamed and normal tissues, and by a human mast cell line. MMPs secreted by these cells could contribute to the extensive matrix lysis characteristic of diseases such as rheumatoid arthritis and inflammatory ocular disorders. Alternatively collagenase-1 production by mast cells may play a critical role in cell invasion and migration into sites of inflam-
INTRODUCTION
Recent studies have focused on the potential importance of mast cells in a variety of inflammatory disorders affecting the integrity of the connective tissue matrix such as rheumatoid arthritis (RA) (Godfrey et al., 1984) and asthma (Galli, 1993) . Mast cells have been shown to play a key role in initiating inflammatory responses, via their release of pro-inflammatory mediators such as cytokines (Gordon and Galli, 1990) , growth factors (Powers et al., 1997) , chemokines Moller et al., 1993) , histamine and proteases (McNeil, 1996) . Proteases such as tryptase and chymase serve as specific markers for mast cells (Schwartz, 1994) . Tryptase has been shown to degrade fibronectin (Lohi et al., 1992) and chy-132 NICK DI GIROLAMO and DENIS WAKEFIELD mase is active against basement membrane proteins such as collagen type IV and V, laminin and fibronectin (Vartio et al., 1981 (Mauviel, 1993; Ries and Petrides, 1995) oncogene products, and cell-to-cell or cell-to-matrix interactions. The activity of MMPs on ECM proteins is inhibited by the TIMPs. TIMPs bind MMPs forming a stable noncovalent and irreversible 1:1 stoichiometric complex. In addition to their roles as MMP inhibitors, TIMPs display growth factor-like activity (Stetler-Stevenson et al., 1992) and promote apoptosis (Guedez et al., 1998 (Saarinen et al., 1994) and results have demonstrated the cleavage of pro-collagenase in a time and dose dependent manner. The mast cell tryptase-dependent activation of pro-collagenase has been shown to be dependent entirely on the activation of pro-stromelysin (Gruber et al., 1989) . Despite these investigation, the precise mechanism(s) of MMP activation in vivo remain unclear.
Observations of the association of mast cells with areas of connective tissue destruction and MMP expression have previously been reported at sites of tumor invasion (Dabbous et al., 1986) , at regions of joint destruction in RA (Tetlow and Woolley, 1995; Gotis-Graham and McNeil, 1997) , in areas of matrix degradation in scleritis (Di Girolamo et al., 1998a; Di Girolamo et al., 1998b) , in atherosclerotic plaques (Johnson et al., 1998; Kaartinen et al., 1998) and in the human endometrium throughout the menstrual cycle (Salamonsen and Woolley, 1996) (D-F) and normal human conjunctiva (G-I) were immunohistochemically analyzed for the expression of tryptase (A, D, G), collagenase-1 (B, E, H), chymase (C, F, I). Some sections were incubated with preabsorbed anti-collagenase-1 mAb (inset C), an isotype control Ab (inset F) or in the absence of a primary Ab (inset I). Immunoreactivity is denoted by the red cytoplasmic staining, with hematoxylin establishing the background nuclear staining. Arrowheads and arrows identify the same mast cell in two or three contiguous tissue sections respectively. These results are representative of all tissue examined. Original magnification X500 for sections A-C and X640 for sections D-I (see Color Plate IX at the back of this issue) and their typical perivascular localization (Fig A-F) . In contrast, fewer mast were detected in all normal tissue analyzed (Fig 1 G-I (Fig D-F) , whereby collagenase-1 producing cells (Fig 1E) , co-expressed chymase ( Fig 1F) . Similarly, tryptase ( Fig 1G) and chymase (Fig lI) positive mast cells in normal ocular tissue stained positively for collagenase-1 (Fig 1H) In situ hybridization using a digoxigenin-labeled riboprobe on human pterygium (Fig 2A) and other diseased and normal tissue (micrographs not shown) demonstrated specific cytoplasmic hybridization signal for collagenase-1 mRNA transcripts in toluidine blue positive mast cells (Fig 2B) . Additional hybridization signal for this transcript was observed in resident connective tissue cells (data not shown). Sections hybridized with the corresponding sense probe resulted in no signal (Fig 2A, inset) . Examina Figure 3 , these cells contain distinct granular immunoreactivity for tryptase (Fig 3A) but not chymase (A, inset). Like their in vivo counterparts, HMC-1 expressed cytoplasmic collagenase-1 (Fig 3B) and some cells contained gelatinase B (Fig 3C) and TIMP-1 (Fig 3D) immunoreactivity. TIMP-2 and-3 could not be detected by this method (micrographs not shown). To determine whether cell-to-cell contact induced collagenase-1 secretion, HMC-1 cells were co-cultured with human scleral fibroblasts (HSF) (cells that express little collagenase-1 even when stimulated with pro-inflammatory cytokines) (Di Girolamo et al., 1995) . In this set of experiments, HSF were allowed to grow to semiconfluence, after which HMC-1 cells were added. Conditioned media (CM) derived from co-culture experiments displayed increased collagenase-1 immunoreactivity (Fig 4, lane 3 ). In contrast, CM derived from HSF or HMC-1 alone demonstrated little or no reactivity for this proteinase (Fig 4, lanes 2 and 4 respectively (Fig 5, lane 1) . Interestingly, the addition of A23187 (degranulating agent) resulted in no increase in the intensity of the 54-kDa immunoreactive band compared to control levels (Fig 5, lane 3) . These results suggest that collagenase-1 is not stored in mast cell granules but secreted upon synthesis. The 54-kDa band detected in HMC-1 CM co-migrated precisely with the previously characterized collagenase-1 derived from human synovial fibroblasts (Fig 5, lane 4) . These data also confirm the specificity of the collagenase-1 mAb used in Figures 1, 3 (Fig 7A, lane 2) , whereas TIMP-2 was induced by PMA ( Fig 7B, lane 2) . TIMP-3 mRNA was not detected by HMC-1 cells (Fig 7C) , but was in human scleral fibroblasts (HSF) (Fig 7C, lane 3) . Amplification of GAPDH mRNA (Fig 7D) (Declaux et al., 1996) . Alternatively, the production of MMPs by mast cells could contribute to the extensive tissue degradation in diseases such as RA (Tetlow and Woolley, 1995; Gotis-Graham and McNeil, 1997) , cancer (Dabbous et al., 1986) , asthma (Galli, 1993) , inflammatory ocular diseases (Di Girolamo et al., 1998a; Di Girolamo et al., 1998b) , and in the normal remodelling which occurs in the human endometrium (Salamonsen and Woolley, .1996) . It is interesting to note that these previous studies failed to identify MMPs in human mast cells. This discrepancy could have been due to the source of primary Ab, as the tissue fixative was generally similar to that used in present study. The specificity of the collagenase-1 mAb used in the current study was verified by antibody/antigen preabsorption (Fig 1C, inset) , and Western blotting (Figs 4 & 5) , where a single immunoreactive species which migrated to approximately 54-kDa was observed. Corroborating evidence has recently been presented by several investigators who have localized stromelysin-1 (MMP-3) to murine mast cells (Brownell et al., 1995) and gelatinase B to dog mast cells (Fang et al., 1996) . There is however one study which disputes the results of the present study, and suggests that interstitial collagenase actually binds mast cell granules (Krejci et al., 1992 (Fig 1B, E, H) . In addition, there was no evidence of degranulation in the tissue sections analyzed. Secondly, mast cells expressed collagenase-1 mRNA transcripts (Fig 2A) , and thirdly, HMC-1 cells secreted detectable levels of collagenase-1. The function of mast cell serine proteases chymase and tryptase are yet to be fully elucidated, although they have been shown to have differing substrate specificity. Saarinen et al (1994) have recently demonstrated the specific cleavage of procollagenase-1 by human mast cells chymase, and similar data was presented by Suzuki et al (1995) who showed that rat mast cell proteinase II (an enzyme equivalent to human chymase) activated procollagenase-1. The Western blotting data presented in the current study showed that the collagenase-1 secreted by HMC (1996) who showed that not only were dog mast cells capable of producing gelatinase B, but this enzyme could be activated by chymase derived from the same cells after degranulation. Similarly, we have previously demonstrated that HMC-1 cells are capable of producing stromelysin-1, and that supernatants derived from these cells contained active enzyme (Di Girolamo et al., 1998a or after exposure to PMA (lane 2). In the presence of reverse transcriptase and gene specific primers for TIMP-1 (A), TIMP-2 (B), Girolamo et al., 1997; Di Girolamo et al., 1998b) . Reverse transcription was performed according to the manufacturer's instructions, using the "Preamplification System for First Strand cDNA Synthesis Kit" (Gibco BRL, Gaithersburg, MD). Aliquots (lgL) of cDNA were amplified by PCR using 100nM each of the forward and reverse gene specific primer (GSP) (see Table I ), using similar conditions to those previously described (Di Girolamo et al., 1998b) . Semi-quantitative PCR was established by terminating reactions at regular intervals of 10, 15, 20, 25, 30, and 35 cycles for each primer pair to ensure that the products formed were within the linear portion of the amplification curve. PCR conditions of temperature, cycle number and length, and restriction enzyme digestions were performed precisely as described previously (Di Girolamo et al., 1998b) . Products were visualized on 1.2% agarose gels stained with ethidium bromide.
SDS-PAGE Gelatin-Substrate Zymography
Gelatin-substrate zymography was performed as previously described (Di Girolamo et al., 1997; Di Girolamo et al., 1998b) . Some gels were incubated with 1, 10-phenanthroline (lmmol/L) or EDTA (10mmol/L) (Sigma), both potent MMP inhibitors.
Western Blot Analysis
Western blotting was performed as previously described (Di Girolamo et al., 1997; Di Girolamo et al., 1998a; Di Girolamo et al., 1998b ) using a mouse anti-human collagenase-1 mAb (ICN Biochemicals, Sydney, Australia). Membranes were placed in a chemiluminescent reagent for non-radioactive detection of proteins (Dupont, Sydney, Australia) to amplify the immunoreactive signal, then exposed to X-ray film.
